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Abstract A short chain peptide has been isolated from the
venom of a red scorpion of Indian origin, Buthus tamulus.
This peptide was puri¢ed using ion exchange and reverse phase
chromatography and was characterized by molecular weight de-
termination and amino acid sequence. The primary structure
analysis shows that BtITx3 is a short peptide of 35 amino
acid residues having a molecular weight of 3796 Da. The toxin
shows toxicity towards the Lepidopteran species of insect Heli-
coverpa armigera causing £accid paralysis and even death with-
in 24 h. It shows more than 50% homology with the short
insectotoxins having four disul¢de bridges, which suggests that
the toxin belongs to the class of short chain toxins blocking the
chloride ion channels. This sequence homology study has also
helped to bring out the structure^function relationship between
the various short toxins. Homology modeling done by using
template structure of a known toxin indicated that this toxin
consists of a similar K/L sca¡old, as present in other scorpion
toxins. 2 2002 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
Scorpion venom consists of numerous polypeptides [1],
many of which can interfere with the activity of ion channels
and modulate their functional properties. These polypeptides
have been used as tools to isolate ion channels and to study
the pharmacology [2] and molecular mechanism of action of
the ion channels. They possess similar structural sca¡olds but
have di¡erent binding properties, which can be used as power-
ful tools for probing the structural aspect of toxin^receptor
interactions. The sodium channel inactivating toxins acting on
rats as well as insects have similar active sites in spite of their
structural and pharmacological di¡erences [3]. These polypep-
tides have di¡erent physiological and pharmacological activ-
ities [4]. They are speci¢c towards mammals, insects [5] and
crustaceans [6]. The anti-insect toxins have been largely used
as a means for biological insect control [7,8]. Scorpions be-
longing to the Buthidae family are medicinally important and
more toxic than the other scorpion species.
Scorpion toxins can be divided into four groups depending
on their physiological and pharmacological activities. The ¢rst
class belongs to the toxins acting on the Naþ channels, which
consists of 60^70 amino acid residues and four intermolecular
disul¢de bonds. These long chain toxins modulate the activa-
tion or the inactivation mechanism of the Naþ channels and
are classi¢ed into 10 subfamilies [9]. The second class of toxins
acting on the Kþ channel has been further divided into three
more classes ^ K-KTx with 23^40 amino acid residues having
three or four disul¢de bonds [10], L-KTx consisting of pep-
tides with 60^64 amino acid residues and only three disul¢de
bonds [11] and Q-KTx having a peptide named Erg-Tx1 [12].
The third class of scorpion toxins acting on the chloride chan-
nels has 35^37 amino acids residues with four disul¢de bonds
[13]. The fourth class includes toxins that act on Ca2þ chan-
nels. There are two peptides in this class consisting of 33 and
27 amino acid residues respectively, which modify the rayo-
dine-sensitive Ca2þ channels [14,15]. Potassium channel toxins
have been studied more extensively as compared to chloride
channel toxins [16]. Chlorotoxin, a chloride channel blocking
toxin isolated from the scorpion Leiureus quinquestriatus,
shows highest homology with short insect toxins [17]. This
toxin has provided some lead in the therapy of brain cancer
[18]. All these scorpion toxins have long been studied to reveal
the structure of the ion channels and to understand the mech-
anism of toxin^receptor interaction.
The Indian scorpion (Mesobuthus tamulus) is a dangerously
venomous species, especially for children [19]. It is medically
the most important species of scorpion on the Indian subcon-
tinent. There are reports on the characterization of active
fractions from the scorpion venom Buthus tamulus that not
only act on various ion channels but are also found to be
protease inhibitors and histamine releasers [20]. Iberiotoxin
isolated from B. tamulus venom is a unique and highly speci¢c
blocker of high conductance calcium-activated potassium
channel and has been completely characterized [21]. Tamulus-
toxin is another toxin isolated from B. tamulus venom, which
is active on the Kþ channel [22]. Bt-II, a mammalian-speci¢c
toxin [23], and ButaIT, an insect-speci¢c toxin, are also iso-
lated from B. tamulus [24].
This paper describes the isolation, puri¢cation, and se-
quence determination of a short toxin, BtITx3, isolated
from the Indian scorpion B. tamulus. This toxin shows signi¢-
cant homology with other short insectotoxins like I5A, chlo-
rotoxin etc. It is toxic towards the insects belonging to the
Lepidopteran species Helicoverpa armigera. An attempt has
been made to compare the amino acid sequences of short
chain toxins which are Kþ and Cl3 ion channel blockers
with that of BtITx3 to understand the structure^activity rela-
tionship of the isolated peptide reported here. The three-di-
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mensional structure was generated with the help of Swiss PDB
modeler to study the structural sca¡old of the toxins, which
along with the knowledge of the net charge from the primary
sequence helps us to identify the residues responsible for se-
lectivity for the insect chloride channel. This further helps to
delineate the di¡erence in the binding capacity of the toxin to
various ion channels.
2. Materials and methods
2.1. Materials
All solvents used for separation were of high performance liquid
chromatography (HPLC) grade obtained from Spectrochem (India).
The chemicals used for sequencing were purchased from Wako (Ja-
pan). Bovine serum albumin used as a standard for protein assay was
obtained from SRL (India). All chemicals used for preparation of
bu¡ers were of analytical grade. All bu¡ers were ¢ltered through
0.45 Wm ¢lters (Sartorius, USA). The crude venom was ¢ltered using
0.2 Wm ¢lters (Pall Gelman Labs, USA). Peptide sequencing was done
on a gas phase sequencer (PPSQ-10) from Shimadzu, consisting of a
HPLC system with a reverse phase C18 column (4.6U250 mm), a
SPD-10 UV detector and a multi-window chromatogram integrator
CR-7A. Absorbance was measured on a UV-265 spectrophotometer
from Shimadzu. The polyvinylidene di£uoride (PVDF) membrane
used for immobilizing the protein was Immobilon-PSQ from Milli-
pore. Centrifugation was done in a Beckman J2-21M/E using a J-18
rotor, and in a Beckman micro-centrifuge using a ¢xed angle rotor.
The column used for ion exchange chromatography was a strong
cationic column, Resource S (1 ml) (6.4U30 mm) from Pharmacia,
and reverse phase HPLC was done on C4 and C18 semi-preparative
columns (22U250 mm) from Vydac. A speed vac concentrator (Sa-
vant) was used for lyophilization of the protein samples.
2.2. Sample preparation
Venom from the scorpion B. tamulus was obtained in a lyophilized
state, from Ha¡kine Institute, Parel, Mumbai, India. The crude ven-
om (60 mg) was weighed and dissolved in 20 ml of water and stirred
at 4‡C for 4 h. The solution was centrifuged at 13 300Ug at 4‡C for
20 min to separate the mucous material of the venom. The clear
supernatant was separated and the pellet was resuspended in 20 ml
water and stirred for 4 h and again centrifuged. The two supernatants
were pooled and ¢ltered through a 0.2 Wm ¢lter and then lyophilized
in a speed vac concentrator. Protein estimation was done by Lowry’s
method using bovine serum albumin as standard [25]. This aqueous
extract was used for further puri¢cation.
2.3. Puri¢cation
The ¢ltered aqueous crude venom extract was used for isolation of
various peptides. The aqueous extract was applied on a Resource S
(1 ml) (Pharmacia, 6.4U30 mm) cation exchange HPLC column,
equilibrated with 20 mM sodium acetate bu¡er, pH 5. The column
was eluted with 20 mM sodium acetate bu¡er, pH 5 using a linear
gradient of 0^0.5 M NaCl at a £ow rate of 0.5 ml/min. The elution
pro¢le showed several peaks (S1^S9). These were collected separately
and the absorbance was measured at 215 nm. The fraction eluting at
25 min was one of the major peaks (S4). This fraction was collected
and lyophilized in a speed vac concentrator and was subjected to
further puri¢cation on a C4 Vydac semipreparative reverse phase
HPLC column (22U250 mm), equilibrated with 0.1% of tri£uoroace-
tic acid (TFA) in water [26]. Separation was done using a linear
gradient of 0.1% TFA in acetonitrile from 15 to 100%. The absor-
bance was measured at 215 nm as well as 280 nm. Various fractions
eluting from the column were collected. These fractions were lyophi-
lized and applied on a C18 (Vydac) semi-preparative reverse phase
HPLC column for ¢nal puri¢cation. Separation was done using a
linear gradient of 0.1% TFA in acetonitrile starting from 15 to
100%. The eluted fractions were collected and once again lyophilized.
2.4. Mass spectroscopy
MALDI-TOF (matrix-assisted laser desorption ionization-time of
£ight) analysis was performed on a Kratos Analytical system (Man-
chester, UK). The method used for sample preparation was the dried
drop method. A volume of 0.5 Wl (1.0 pmol/Wl) was spotted on the
plate, followed by 0.5 Wl of the matrix CHCA (K-cyano-4-hydroxycin-
namic acid) solution and dried at room temperature. The nitrogen
laser used for the desorption of the sample was kept at 337 nm.
2.5. Sequence analysis
The primary sequence of the toxin was determined by Edman deg-
radation reaction using the PPSQ-10 sequencer from Shimadzu
equipped with an LC-10A HPLC system and C18 reverse phase
HPLC column. The scorpion toxins are known to have three to
four disul¢de bonds, hence to determine the position of cysteine res-
idues the peptides have to be ¢rst reduced and alkylated. The toxin
was immobilized on Immobilon-PSQ PVDF (Millipore) and 5 Wl of
the mixture of 0.6% tri-n-butylphosphine and 1.2 Wl of 4-vinylpyridine
in 80% isopropanol was added for the simultaneous reduction and
alkylation of the toxin successively followed by Edman degradation
reaction. The optimal reaction temperature and time for the reaction
were 60‡C and 50 min respectively.
2.6. Toxicity test
The toxicity test was done on the cotton bollworm H. armigera that
is a serious polyphagous noctuid that damages a number of crops in
India. The larva used for test was in the early fourth instar stage, 25
mm long and weight ranging from 90 to 120 mg. The crude venom
was dissolved in water and injected in various concentrations to de-
termine the LD50. The puri¢ed fraction was also dissolved in water
and injected into the thoracic region of the larva. The control was
injected with 5 Wl of water. Symptoms of contraction for 5^10 s were
taken as a positive response and paralysis was observed continuously
for a period of 30 min. The insect was kept under observation for 24 h,
post injection.
2.7. Homology modeling
The multiple sequence alignment was done using CLUSTALW.
One-dimensional homology modeling of the sequence was done using
the BLASTP algorithm at the URL http://sdmc.krdl.org.sg:8080/scor-
pion/ over the Scorpion toxin database. The sequences were also
aligned using the BLASTP algorithm [27]. Scoring was done using
the BLOSUM62 matrices [28]. We used Swiss Modeler to generate
the model. This model was then subjected for check to the commonly
used WHAT IF [29] and PROCHECK programs [30]. The ¢nal model
structure thus obtained was then subjected to re¢nement by energy
minimization in Swiss Modeler using a GROMOS96 force ¢eld.
3. Results
3.1. Puri¢cation of the toxin
The crude venom (60 mg) was fractionated using a strong
cationic Resource S column, which gave nine fractions. The
nine eluted fractions were collected and numbered S1^S9.
These fractions were tested for biological activity in H. armi-
gera. Fraction S4, one of the major peaks eluting at 25 min
and also active against H. armigera, was taken up for further
puri¢cation. This fraction was loaded on a C4 reverse phase
HPLC column and eluted using a linear gradient of acetoni-
trile (Fig. 1A). Three major peaks were isolated from this
column. Of these three peaks, the peak that eluted at 17.8
min was further puri¢ed to homogeneity by reverse phase
HPLC on a C18 column. The ¢nal puri¢ed protein eluted at
21.4 min (Fig. 1B) and was named BtITx3. About 40^50 Wg
(0.15%) of the puri¢ed fractions was obtained from 60 mg of
the crude venom.
3.2. Bioassay
The crude venom was injected into the thoracic region of
fourth instar larvae of the insect H. armigera, in di¡erent
concentrations, and its LD50 was found to be 5.31 Wg/100
mg of larva. The larvae showed symptoms of contraction
for 5^10 s after injection leading to severe paralysis, which
was monitored for 30 min. The puri¢ed fraction was also
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injected into larvae in a similar manner as the crude venom.
The toxin was found to be e¡ective at a dose of 2 Wg/100 mg
of larva. The e¡ect of the toxin showed initial contraction and
then severe paralysis was observed for more than 30 min and
the larva was dead within 24 h. Thus BtITx3 was found to be
a lethal toxin.
3.3. Structural analysis
The primary sequence analysis of this peptide shows that
this is a short chain peptide with four disul¢de bridges. Cys-
teine identi¢cation is typically di⁄cult while sequencing pep-
tides using the Edman degradation reaction, because its phen-
ylthiohydantoin derivative is unstable and thus cysteine is
reduced and alkylated with tri-n-butylphosphine and 4-vinyl-
pyridine respectively. The primary structure of BtITx3 shows
the presence of 35 amino acid residues with eight cysteine
residues. The multiple sequence alignment of this peptide
shows considerable homology (Fig. 2) with the short insecto-
toxins, which block the chloride channels. The primary se-
quence analysis of the peptide gave the following sequence:
BtITx3 RCPPCFTTNPNMEADCRKCCGGRGYCASYQ-
CICPG.
The molecular mass of the puri¢ed peptide BtITx3 as de-
termined by MALDI-TOF was 3796.5 Da (Fig. 3), which is in
good agreement with the calculated molecular weight of 3798
Da. The insectotoxins have been divided into long and short
Fig. 1. Puri¢cation of the water extract of the crude venom from B. tamulus. The crude venom (60 mg) was fractionated using a strong cationic
Resource S column, which gives nine fractions, S1^S9. A: The labeled fraction (*) was puri¢ed by loading on a Vydac C4 reverse phase HPLC
column equilibrated with 0.1% TFA in water. The elution was carried out by a linear gradient of 0.1% TFA in 15^100% acetonitrile. The £ow
rate was 2.4 ml/min and fractions were monitored at 215 nm. Fractions were collected and lyophilized. B: The ¢nal puri¢cation was done on a
Vydac C18 reverse phase column. The peak labeled BtITx3 was collected and used for further processing.
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insect toxins [26], which block the sodium and the chloride
channel respectively. The multiple sequence alignment of the
isolated toxin was done on the basis of similar cysteine posi-
tions, and other conserved N- and C-terminal residues. The
toxin was found to be highly homologous to the short insect
toxins, which belong to the chloride channel blocking cate-
gory. The toxin BtITx3 shows the highest homology (Fig. 2)
with the insectotoxins I5A, ITI1, I4, I5 and I3 (62.5%, 59.4%,
59.4%, 59.4% and 53.1% respectively) from Buthus eupeus [31],
AmmP2 (59.4%) from Androctonus mauretanicus [4], ClTx,
ClTx-a, b, c and d (50.0%, 50.1%, 52.9%, 55.9% and 53.1%
respectively) from Leiureus quinquestriatus quinquestriatus
[13], Bs8 (51.5%) and Bs14(53.1%) from Mesobuthus sindicus
[32,33] and LQH-8/6. (51.5%) from L. quinquestriatus hebraeus
[34]. Short insectotoxins have a net charge ranging from +2 to
+5, making them basic peptides. The net charge observed on
this peptide is +2, which also falls in the same range.
The alignment of the primary sequence of BtITx3 shows
50^60% homology with the short insect toxins based on which
the three-dimensional structure of I5A (1SIS) was taken as the
template to build the model structure of the desired toxin.
BtITx3 was modeled with the template structure of the Meso-
buthus eupeus toxin (I5A) [35] previously determined by nu-
clear magnetic resonance (NMR) (1SIS), showing one K-helix
from Asn11 to Asp18 and a L-sheet consisting of three
L-strands, one from Met3 to Cys5, the second from Lys25
to Phe27 and the third from Pro29 to Leu32 (Fig. 4). The
¢nal modeled structure also has one K-helix from Asn11 to
Lys18 and a L-sheet consisting of three L-strands, one of them
from Pro3 to Cys5, the second from Tyr25 to Ala27 and the
last one from Tyr29 to Ile32. The quality of the model for
BtITx3 was assessed using the program WHAT IF, which
showed that the model was as good as that of the homologous
toxin structure 1SIS, implying good stereochemical quality.
The PROCHECK report shows that the model has a Rama-
chandran score of 75.5, which is close to that of the template
76.9. Other stereochemical properties are also in agreement
with that of the template, which indicates that the model
structure of BtITx3 shows a similar sca¡old as possessed by
the other short insectotoxins blocking the chloride channel.
Fig. 2. Amino acid sequence of BtITx3 showing multiple sequence alignment with the short insectotoxin. The target sequence has been aligned
based on the positions of cysteine as well as the other conserved residues present in the short insectotoxins. The percentage identity between
the toxins and the net charge associated with them are shown on the right. The ¢gure shows homology between the following toxins I5A,
ITI1, I4, I5 and I3 from Buthus eupeus [31], AmmP2 from Androctonus mauretanicus [4,31], ClTx, ClTx-a, b, c and d from Leiureus quinques-
triatus quinquestriatus [4,13], Bs8 and Bs14 from Mesobuthus sindicus [32,33], LQH-8/6 from L. quinquestriatus hebraeus [34], ButaIT from B. ta-
mulus [24]. The pattern of disul¢de bridges as determined by the structure of chlorotoxin is shown in this ¢gure. Regions of secondary structure
as K-helix (gray bar) and two antiparallel L-strands (black bar) are also indicated.
Fig. 3. MALDI-TOF mass spectrum of BtITx3.
Fig. 4. The three-dimensional structure of BtITx3 derived by Swiss
Modeler taking the NMR coordinates of insectotoxin I5A. The
structure was visualized on Weblab viewer. The structure shows a
K/L sca¡old with one K-helix and three L-strands.
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4. Discussion
Scorpion toxins show a similar K/L sca¡old despite the large
variation in their size, origin and functional properties. The
three-dimensional structure mainly consists of a small three-
stranded antiparallel L-sheet packed against an K-helix (N-
terminal), which is roughly parallel to the L-sheet. The two
L-strands are linked to the K-helix by three disul¢de bonds in
the case of the chloride channel toxins and two in the case of
the potassium channel toxins [36]. The multiple sequence
alignment among the short insect toxins shows a high degree
of consensus. The toxin BtITx3 shows a similar pattern of
cysteine residues as that found in the chloride channel block-
ers. There is a remarkable feature of the chloride channel
blocking toxins, showing a major di¡erence in the K-helix,
with a shift of one turn toward the N-terminus, whereas in
the case of potassium channel blockers the central part of the
helix has the characteristic C-X-X-X-C motif. Thus, the pri-
mary structure shows a C-X-X-X-C pattern in potassium
channel blockers and C-X-X-C-C in the case of chloride chan-
nel toxins. The fourth disul¢de bond in the chloride channel
helps to link the N-terminal of the molecule with the rest of
the molecule, while in the case of toxins blocking the potas-
sium channel this is done with the help of the hydrophobic
residues present in the L-turn, which link with the ¢rst residue
at the N-terminal.
The di¡erence in the speci¢city towards various ion channel
toxins is dependent on the key residues of the toxin, which
bind with the ion channel receptor. The distribution of func-
tionally important residues involved in the toxin^channel in-
teraction is di¡erent in chloride channel toxins as compared to
potassium channel toxins. The toxins belonging to the potas-
sium channel family like charybdotoxin have their binding
residues located in the L-sheet, which is the solvent-exposed
part of the toxin. Functionally important residues present in
this region of charybdotoxin are Arg25, Lys27 and Arg34,
which bind to the potassium ion channel. Chloride channel
toxins also show the presence of Arg24 and Lys25, but Arg34
is replaced by Leu or Ile, and the positively charged surface
important for binding the receptor is present in the helical
region.
The primary sequence comparison of the chloride channel
blocking toxin chlorotoxin with that of the potassium ion
channel blocker charybdotoxin shows (Fig. 5) 10 conserved
residues, and similar residues as Arg25, Gly26, Lys27 and
Cys28 residing in one of the L-sheets. Based on the pattern
of primary sequence homology BtITx3 shows 10 residues,
other than the cysteine residues, which are similar to chloro-
toxin and four residues similar to the potassium channel
blocker charybdotoxin. The potassium channel toxins are
known to interact with the outer vestibule of the channel by
the residue Lys27 that occludes the channel [37]. The chloride
channel toxins like chlorotoxin have been found to inhibit
epithelial chloride channel activity only when applied through
the intracellular region. Moreover, the crucial residue Lys27 is
also present in chlorotoxin but it does not bind to the voltage-
gated ion channel as observed in the case of charybdotoxin.
The residues present in the C-terminal L-sheet of chlorotoxin
are similar to that of the potassium channel blocking toxin
charybdotoxin, i.e. Arg25 and Lys27, except Arg34, which is
replaced by neutral residue Leu34. Further in chlorotoxin the
N-terminal helix residues Asp17 and Asp18, just before the
fourth cysteine residue Cys19, neutralize the positive charge
e¡ect of the residues in the C-terminal L-sheet. These func-
tionally important residues in the case of toxin BtITx3 are
replaced by Arg23 and Try25. However, residues Arg17 and
Lys18 are basic unlike the acidic residues in the case of chlo-
rotoxin. This indicates that toxin BtITx3 might have a di¡er-
ent mode of binding the chloride channel. This toxin, how-
ever, does not have the most crucial residue Lys27 which is
actually responsible for the occlusion of the pore of potassium
ion channel.
In conclusion, the insect-selective toxin BtITx3 can be clas-
si¢ed as one of the members of the chloride channel toxins
and further structural and mutagenesis studies are being car-
ried out to understand its molecular mechanism as well as to
exploit its insecticidal activity.
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